搜索临床试验以:Camrelizumab 联合阿帕替尼、依托泊苷和顺铂
总计1778个结果
-
Tianjin Medical University Cancer Institute and...尚未招聘无进展生存期(PFS)
-
Fudan University未知
-
Shoucheng Ma未知
-
Beijing Pearl Biotechnology Limited Liability Company主动,不招人
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人根治性切除或消融后复发风险高的肝细胞癌 (HCC) 患者的辅助治疗中国
-
The Affiliated Hospital of Qingdao University未知
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu Hengrui Pharmaceutical Co., Ltd.未知
-
The First Affiliated Hospital of Zhengzhou University招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.招聘中
-
Sun Yat-sen University主动,不招人
-
Shenzhen People's Hospital未知
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Anhui Shi, MDPeking University First Hospital; Xijing Hospital; Peking University People's Hospital; Sun Yat-sen... 和其他合作者完全的
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Zhejiang UniversityHuashan Hospital; West China Hospital; The First Affiliated Hospital of Zhengzhou University; The... 和其他合作者未知
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Shanghai Junshi Bioscience Co., Ltd.主动,不招人
-
Bristol-Myers Squibb撤销
-
Zhao ChongCancer Institute and Hospital, Chinese Academy of Medical Sciences; Jiangxi Provincial Cancer... 和其他合作者完全的